Marchex, Inc.
NASDAQ:MCHXAdvertising Agencies
+$0.03 today
- Market cap
- $51.59M
- Beta
- 1.89
- P/E (TTM)
- -13.4
- EPS (TTM)
- -$0.11
Volume 0.02M
Average 0.02M
MCHX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Marchex, Inc.NASDAQ: MCHX
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$984K, compared with -$1.49M a year earlier. Trailing-twelve-month EBITDA was -$2.7M.
Context
- EBITDA amounted to 5.5% of revenue in FY2025, up 1.7 pp from a year earlier.
- EBITDA grew in size in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $5.6M (+325.6%) for the fiscal year ending Dec 2026, a step up from the -37.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$984K+41.5% QoQ
- Last fiscal yearDec 2025
- -$2.48M-37.8% YoY
- LTMMar 2026
- -$2.7M+4.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +34.1% | +154.2% | +120.1 pp |
| 1 year | -37.8% | +325.6% | +363.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (2.48M) USD
- Year-over-year change
- -37.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.48M) | -37.8% |
| FY2024 | 2024-12-31 | (1.8M) | +68.7% |
| FY2023 | 2023-12-31 | (5.76M) | -42.9% |
| FY2022 | 2022-12-31 | (4.03M) | -317.8% |
| FY2021 | 2021-12-31 | 1.85M | — |
EBITDA vs competitors
How MCHX compares with its peers on the latest reported figures
- MCHX's LTM Mar 2026 EBITDA of -$2.7M is the 4th highest of the 7 companies compared; the peer median is -$2.95M.
- Its year-over-year change of +4.3% is the 3rd highest of 6, against a peer median of -62.2%.
- EBITDA amounts to 6.0% of revenue for MCHX, versus a peer median of 9.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $52.67M | +23.9% | -5.9% | 12.4% | |
| LTM Mar 2026 | $6.95M | -62.2% | -13.1% | 7.5% | |
| LTM Mar 2026 | $38K | +100.3% | — | 0.1% | |
| LTM Mar 2026 | -$2.7M | +4.3% | — | 6.0% | |
| LTM Mar 2026 | -$5.93M | -165.8% | — | 5.6% | |
| LTM Mar 2026 | -$187.54M | — | — | 857.4% | |
| LTM Mar 2026 | -$585.31M | -891.9% | — | 109.9% | |
| Peer median (excluding MCHX) | -$2.95M | -62.2% | -9.5% | 9.9% | |
Competitors are the stored peer set for MCHX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 53.48M | 52.17M | 49.91M | 48.12M | 45.42M |
| Cost of Revenue | 21.69M | 20.46M | 20.58M | 17.17M | 16.72M |
| Gross Profit | 31.78M | 31.71M | 29.33M | 30.95M | 28.71M |
| Gross Margin | 59.4% | 60.8% | 58.8% | 64.3% | 63.2% |
| Research & Development | 16.11M | 14.36M | 15.36M | 12.41M | 9.75M |
| Selling, General & Admin | 22.84M | 23.3M | 21.62M | 22.38M | 23.33M |
| Operating Expenses | 43.58M | 39.86M | 38.97M | 35.4M | 33.08M |
| Depreciation & Amortization | 5.97M | 4.03M | 3.87M | 2.65M | 2.67M |
| EBITDA | 1.85M | (4.03M) | (5.76M) | (1.8M) | (2.48M) |
| EBITDA Margin | 3.5% | -7.7% | -11.5% | -3.7% | -5.5% |
| Operating Income | (11.8M) | (8.15M) | (9.64M) | (4.45M) | (4.37M) |
| Operating Margin | -22.1% | -15.6% | -19.3% | -9.2% | -9.6% |
| Interest Income | 3K | 99K | 319K | 0 | 0 |
| Interest Expense | 37K | 0 | 293K | 120K | 0 |
| Other Income / Expenses | 7.64M | 88K | (173K) | (120K) | (782K) |
| Income Before Tax | (4.16M) | (8.06M) | (9.82M) | (4.57M) | (5.16M) |
| Pre-Tax Margin | -7.8% | -15.5% | -19.7% | -9.5% | -11.4% |
| Income Tax Expense | 232K | 184K | 94K | 380K | 79K |
| Net Income | (4.39M) | (8.25M) | (9.91M) | (4.95M) | (5.24M) |
| Net Margin | -8.2% | -15.8% | -19.9% | -10.3% | -11.5% |
| EPS (Basic) | (0.10) | (0.19) | (0.23) | (0.11) | (0.12) |
| EPS (Diluted) | (0.10) | (0.19) | (0.23) | (0.11) | (0.11) |
| Weighted Avg Shares | 43.92M | 43.22M | 42.62M | 43.16M | 43.9M |
| Weighted Avg Shares (Diluted) | 43.92M | 43.22M | 42.62M | 43.16M | 48.56M |
Marchex, Inc.
NASDAQ:MCHX
Intrinsic Alpha fair value
Locked
Current Price
$1.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.